Diabetes

WHITEHOUSE STATION, N.J., and BEVERLY, Mass. (Dec. 2) Merck announced on Thursday it has inked a deal to acquire an insulin maker.

NEW YORK — The entire retail store is a diabetes destination, and pharmacists are critical in educating and communicating with consumers to help them and their loved ones better manage the chronic disease. That was one of several important messages that industry leaders expressed during Drug Store News’ 8th Annual Diabetes Roundtable discussion on Tuesday in New York at the New York Athletic Club. More than 100 leading industry players gathered for the event, which also included the 12th Annual Industry Issues Summit in the afternoon.

DEERFIELD, Ill. — Walgreens' chief medical officer will discuss the evidence-based medicine design and impact of a diabetes management program delivered by pharmacists at both workplace and community pharmacies during an upcoming conference, the drug store chain said.

NEW YORK — A new study published in the Nov. 22 issue of Archives of Internal Medicine suggested there is a two-way relationship between depression and diabetes.

WASHINGTON — The number of Americans diagnosed with diabetes and the related costs of the disease could reach catastrophic proportions, according to new research by the UnitedHealth Group.

ST. LOUIS — The Journal of the American Dietetic Association has published a list of nutritional practice guidelines for people with Type 1 and Type 2 diabetes in its December issue.

BOCA RATON, Fla. — Diabetica Research Solutions is spreading the word about its diabetes energy formula with a new media program that targets the New York metropolitan area.

The targeted media program for DRSI ReStore! Energy — which now is available at Duane Reade and Rite Aid pharmacies in the area — supplements the brand's national television campaign, includes high saturation local commercial spots on television and radio, and internet banner ads to appear specifically on Web pages viewed by people in New York and the surrounding area.

ST. LOUIS — Since the beginning of the HIV/AIDS epidemic in the early 1980s, one of the greatest advances has been antiviral drugs that have helped extend the lives of patients with viral infections.